Cargando…
Efficacy and safety of low‐dose sacubitril/valsartan in heart failure patients: A systematic review and meta‐analysis
BACKGROUND: Controversy has persisted over the clinical benefits of low‐dose sacubitril/valsartan in patients with heart failure (HF). HYPOTHESIS: Low‐dose sacubitril/valsartan might also be effective and safe in HF patients. METHODS: Electronic databases including PubMed, Ovid, and Cochrane Library...
Autores principales: | Chen, Wen‐Wen, Jiang, Juan, Gao, Jie, Zhang, Xiu‐Zhen, Li, Yuan‐Min, Liu, Yan‐Lin, Dang, He‐Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018087/ https://www.ncbi.nlm.nih.gov/pubmed/36648084 http://dx.doi.org/10.1002/clc.23971 |
Ejemplares similares
-
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
por: Abdin, Amr, et al.
Publicado: (2022) -
Effects of sacubitril‐valsartan in the treatment of chronic heart failure patients with end‐stage renal disease undergoing dialysis
por: Liu, Xiaoyan, et al.
Publicado: (2023) -
Efficacy and safety of sacubitril‐valsartan in heart failure: a meta‐analysis of randomized controlled trials
por: Zhang, Hongzhou, et al.
Publicado: (2020) -
Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021) -
Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018)